A new breakthrough delivery technology that optimizes the bioavailability and absorption of nutritional supplements, medical foods, and pharmaceutical drugs is now available to consumers and health-care practitioners.
NAPA, Calif., Feb. 27, 2018 /PRNewswire/-- A new breakthrough delivery technology that optimizes the bioavailability and absorption of nutritional supplements, medical foods, and pharmaceutical drugs is now available to consumers and health-care practitioners. Tesseract Medical Research’s (TMR), www.tessmed.com, advancement in nano-nutrient delivery science is a major leap forward in ensuring that nutrients reach their intended target, where they can have maximum efficacy in improving health outcomes. Tesseract products are now available on Amazon and other distribution outlets for those needing relief from symptoms of digestive, neurocognitive, allergy, and a host of inflammatory disorders.
Tesseract innovation is attributable to a two-step approach: each molecule of the active ingredient is caged in its own carrier to safely reach the intestinal tract for maximum absorption via the patent-pending CyLoc™ system. The cage matrix is then broken at the desired release point by TMR’s DexKey™ process and delivered throughout the intestinal tract.
The importance of this new technology is most dramatically illustrated by Tesseract’s supplement called ProButyrate™, which is a short-chain fatty acid supplement that provides a major energy source (butyrate) that feeds the essential bacteria in our gut.* Now well-recognized by researchers as a key modulator of gut-immune-brain health, butyrate is naturally produced in the colon by the fermentation of fiber and starches. For those suffering from irritable bowel syndrome, Crohn’s Disease, and ulcerative colitis, butyrate supplementation has been demonstrated in scientific studies to provide essential nutritional support to help manage the symptoms associated with these conditions.* While pro- and pre-biotic supplementation support a balanced intestinal flora, they are often not effective if short-chain fatty acid production is inadequate.* ProButyrate™ has an innovative delivery technology that solves the longstanding challenge of finding a more effective method to deliver butyrate where it is needed most - the colon.* Previous methods for butyrate supplementation have been via sodium butyrate enema or oral supplementation with butyrate mineral salts, which for most patients are intolerable in taste and smell.
Similarly, Tesseract’s technology is unleashing the full benefits of curcumin, with its new product, TetraCumin™. The CyLoc™ and DexKey™ systems have solved curcumin’s low absorption and short half-life bioavailability of the compound commonly found in the Indian spice turmeric. TetraCumin™ also contains Tetrahydrocurcumin, the form of curcumin the body can most readily absorb to help maintain a healthy inflammatory response.* More specifically, Tetrahydrocurcumin has been found to support a healthier gastrointestinal tract, better cardiovascular health, deliver healthy aging benefits, and provide relief from occasional joint and muscle soreness.*
For seasonal allergy sufferers, Tesseract offers QuerciSorb™, a healthier natural option to most over-the-counter antihistamines. Commonly found in fruits and vegetables, the antioxidant and bioflavonoid quercetin has demonstrated benefit in modulating the body’s exaggerated immune response to allergens. QuerciSorb™ helps to stabilize the body’s mast cells, which then help to bring histamine down to a more comfortable level.* However, research results on quercetin in the lab have not always shown similar outcomes in human trials due to its poor absorption, which is now markedly improved by Tesseract’s delivery science.
Tesseract is the latest innovation from Al Czap, the founder and former CEO of Thorne Research. More than three decades ago, Czap and Thorne recognized how the benefits of nutritional supplements were undermined by inferior quality ingredients that could not be efficiently absorbed by patients with allergies, with impaired immune and digestive systems, or with toxic environmental exposure. In response, Thorne Research created a new industry standard for product purity. TMR’s innovation is a now poised to advance the potential of nutritional medicine to an even higher level. For more information, visit www.tessmed.com.
About Tesseract: (TessMed.com):
Tesseract Medical Research (TMR) is a life sciences company headquartered in Napa, California. They are the developer of breakthrough technology that optimizes the bioavailability and absorption of multiple nutrients, particularly those that are ingredients in nutritional supplements, medical foods, and pharmaceuticals. Tesseract offers a selection of natural supplements that support digestive, neurocognitive, and inflammatory disorders. This ground-breaking nano-nutrient delivery science is the latest innovation from Al Czap, the founder and former CEO of Thorne Research, and is a leap forward in efficacy and ensuring nutrients will reach their intended target.
* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Media Contact:
Leigh-Anne Anderson
191002@email4pr.com
310 990 5752
View original content with multimedia:http://www.prnewswire.com/news-releases/tesseract-medical-research-launches-breakthrough-nutrient-delivery-technology-300604585.html
SOURCE Tesseract Medical Research
